Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Mäder, Peter M.
~ 1400  Ergebnisse:
Personensuche X
?
1

Zinnfiguren, Zinnsoldaten, Zinngeschichte:

Kollbrunner, Curt F. ; Mäder, Peter M. , 1979
Exemplar:  Zentrale:E04 h kun 189.6/120
 
?
2

Dendritic crystallization in hydrous basaltic magmas contro..:

Arzilli, Fabio ; Polacci, Margherita ; La Spina, Giuseppe...
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
3

A First-in-Class, Highly Selective and Cell-Active Alloster..:

Shen, Yudao ; Li, Fengling ; Szewczyk, Magdalena M....
Journal of Medicinal Chemistry.  64 (2021)  7 - p. 3697-3706 , 2021
Link: https://doi.org/10.1021/..
 
?
4

Magma fragmentation in highly explosive basaltic eruptions ..:

Arzilli, Fabio ; La Spina, Giuseppe ; Burton, Mike R....
Nature Geoscience.  12 (2019)  12 - p. 1023-1028 , 2019
Link: https://doi.org/10.1038/..
 
?
5

LLY-283, a Potent and Selective Inhibitor of Arginine Methy..:

Bonday, Zahid Q. ; Cortez, Guillermo S. ; Grogan, Michael J....
ACS Medicinal Chemistry Letters.  9 (2018)  7 - p. 612-617 , 2018
Link: https://doi.org/10.1021/..
 
?
6

The germacranolide sesquiterpene lactone neurolenin B of th..:

Unger, Christine ; Kiss, Izabella ; Vasas, Andrea...
Phytomedicine.  22 (2015)  9 - p. 862-874 , 2015
Link: https://doi.org/10.1016/..
 
?
7

Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic..:

Kiss, Izabella ; Unger, Christine ; Huu, Chi Nguyen...
Cancer Letters.  356 (2015)  2 - p. 994-1006 , 2015
Link: https://doi.org/10.1016/..
 
?
8

Ovarian function suppression and fulvestrant as endocrine t..:

Bartsch, Rupert ; Bago-Horvath, Zsuzsanna ; Berghoff, Anna...
European Journal of Cancer.  48 (2012)  13 - p. 1932-1938 , 2012
Link: https://doi.org/10.1016/..
 
?
9

Ranolazine Reduces Ventricular Tachycardia Burden and ICD S..:

BUNCH, T. JARED ; MAHAPATRA, SRIJOY ; MURDOCK, DAVID...
Pacing and Clinical Electrophysiology.  34 (2011)  12 - p. 1600-1606 , 2011
Link: https://doi.org/10.1111/..
 
?
10

Predicting for activity of second-line trastuzumab-based th..:

Bartsch, Rupert ; De Vries, Catharina ; Pluschnig, Ursula...
BMC Cancer.  9 (2009)  1 - p. , 2009
Link: https://doi.org/10.1186/..
 
?
11

Trastuzumab and gemcitabine as salvage therapy in heavily p..:

Bartsch, Rupert ; Wenzel, Catharina ; Gampenrieder, Simon P....
Cancer Chemotherapy and Pharmacology.  62 (2008)  5 - p. 903-910 , 2008
Link: https://doi.org/10.1007/..
 
?
12

Osteoclast-like giant cell tumor in mucinous cystadenocarci..:

Sedivy, Roland ; Kalipciyan, Maria ; Mazal, Peter R....
Cancer Detection and Prevention.  29 (2005)  1 - p. 8-14 , 2005
Link: https://doi.org/10.1016/..
 
?
13

Prognostic markers in breast cancer: the reliability of HER..:

Taucher, Susanne ; Rudas, Margaretha ; Mader, Robert M....
Wiener Klinische Wochenschrift.  116 (2004)  1-2 - p. 26-31 , 2004
Link: https://doi.org/10.1007/..
 
?
14

Influence of Neoadjuvant Therapy with Epirubicin and Doceta..:

Taucher, Susanne ; Rudas, Margaretha ; Mader, Robert M....
Breast Cancer Research and Treatment.  82 (2003)  3 - p. 207-213 , 2003
Link: https://doi.org/10.1023/..
 
?
15

Do we need HER‐2/neu testing for all patients with primary ..:

Taucher, Susanne ; Rudas, Margaretha ; Mader, Robert M....
Cancer.  98 (2003)  12 - p. 2547-2553 , 2003
Link: https://doi.org/10.1002/..
 
1-15